Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus nalbuphine for prevention of emergence delirium after functional endoscopic sinus surgery
PACTR202508566892312Phase 0Recruiting
- Sponsor
- Faculty of Medicine, Menoufia University
- Start
- May 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of dexmedetomidine and nalbuphine in Emergence agitation (EA) (2 arms), sponsored by Faculty of Medicine, Menoufia University. Primary endpoint: Prevention of emergence delirium. Started May 2025; status: recruiting.
02
Drugs
dexmedetomidinenalbuphine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on PACTR202508566892312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202508566892312.